[Thymo-lymphatic atrophy in an infant following long-term ACTH therapy].
D000324:Adrenocorticotropic Hormone / Q000009:adverse effects*; D001284:Atrophy; D003480:Cushing Syndrome / Q000188:drug therapy; D004804:Eosinophils; D005260:Female; D006801:Humans; D007082:Ileum / Q000473:pathology; D007223:Infant; D007970:Leukopenia / Q000139:chemically induced; D008168:Lung / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D008206:Lymphatic Diseases / Q000139:chemically induced*; D014066:Palatine Tonsil / Q000473:pathology; D010950:Plasma Cells; D013035:Spasm / Q000188:drug therapy; D013036:Spasms, Infantile / Q000188:drug therapy; D013154:Spleen / Q000473:pathology; D013950:Thymus Gland / Q000473:pathology*; D013997:Time Factors
D000324:Adrenocorticotropic Hormone
L'atrophie thymo-lymphatique chez le nourrisson après traitement prolongé à l'ACTH.